Syapse

About:

Syapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care

Website: https://syapse.com/

Twitter/X: Syapse

Top Investors: Northpond Ventures, Revelation Partners, Safeguard Scientifics, Amgen Ventures, Merck Global Health Innovation Fund

Description:

To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions that matter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond.

Total Funding Amount:

$223M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2008-03-12

Contact Email:

hello(AT)syapse.com

Founders:

Jonathan Hirsch, Tony Loeser

Number of Employees:

101-250

Last Funding Date:

2022-07-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai